Navigation Links
Regenetek Research Inc. Launches New Intelligent Software for Therapeutic Stem Cell Trials
Date:12/11/2012

WINNIPEG, Manitoba, Dec. 11, 2012 /PRNewswire/ -- Doug Broeska, Ph.D., CEO of Regenetek Research Inc., an international medical research company with offices in Canada and India has announced that they are launching new web-based, self-managing, clinical trial software that amongst other things will be able to extend patient Registry information into individual patient case studies and aggregate the data with comparisons to cohorts. The company has so far specifically focused their new technology on a number of autologous therapeutic stem cell trials for a range of neurologic diseases that are taking place in multiple centers worldwide. Such software would have important application where limited financial resources are combined with the need to validate efficacy and prove reproducibility of therapy protocols.

"The ability to rigorously evaluate individual patients, monitor adverse events, and aggregate data from different patients in different centers while maintaining ethical standards will achieve better control of bias, generate greater statistical power, and produce more meaningful conclusions for clinical outcomes," says Dr. Broeska, CEO of Regenetek Research. Indeed, for cases where every patient's cells are unique, randomized controlled trials are simply not possible as an appropriate design for clinical investigation.

"This is just getting back to the basics of medical research. A lot of medical investigation used to be done this way," says Broeska. "Many medical breakthroughs were made only through observations with an N of one, but now we have the advantage of being able to handle big data through new technologies. We can chart the outcomes of many individual patient case studies over time, aggregate, and even compare the data in a meaningful way to produce valid evidence. We are not limited to therapeutic stem cell research but that is an obvious place to start. Moving all medical investigation forward, faster is our goal."

Inquiries may be directed to Dr. Doug Broeska at "info@regenetek.com" or call 204-975-9665.

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Regenetek Research Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Scientific Research & Development in the US Industry Market Research Report from IBISWorld has Been Updated
2. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
3. France & Germany Blood Banking Market: Innovative Technologies and Emerging Business Opportunities in New Research Report at ReportsnReports.com
4. UT Arlington research team wins $1.35 million NSF robotics grant to develop smart skin applications
5. Premier Biomedical Successfully Advances Cancer Research
6. US Natural Polymers Market Forecasts to 2016 in New Research Report at ReportsnReports.com
7. Leuven research opens new pathway for the treatment of Alzheimers disease
8. Industrial carbon management research gets $3.75 million boost
9. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
10. ArteryHealth.org Launches as a Collective Database of Artery Health Research
11. Research discovery could revolutionize semiconductor manufacture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
Breaking Biology Technology:
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
Breaking Biology News(10 mins):